Sciences Hacker News May 12, 2026 1 min read
UCLA researchers have identified DDL-920, the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice. The findings, published in Nature Communications, could transform stroke recovery into a pharmacological option.